Acciones del sector sanitario
| Industries (11) | ||||
|---|---|---|---|---|
| 1.14 T USD | -0.02% | 0.04% | 555 | |
| 927.11 B USD | 0.00% | 0.27% | 53 | |
| 4.04 T USD | -0.02% | 1.59% | 50 | |
| 273.91 B USD | -0.02% | 0.54% | 72 | |
| 157.29 B USD | +0.01% | 0.07% | 49 | |
| 780.89 B USD | -0.02% | 1.91% | 10 | |
| 259.10 B USD | 0.00% | 0.37% | 48 | |
| 814.00 B USD | 0.00% | 0.87% | 137 | |
| 248.55 B USD | -0.02% | 0.53% | 7 | |
| 436.50 B USD | 0.00% | 0.42% | 54 | |
| 258.76 M USD | -0.02% | 0% | 4 |
Noticias Acciones del sector sanitario
Fármaco de J&J contra el cáncer de próstata muestra resultados prometedores
Compass Therapeutics publica resultados del ensayo de tovecimig en JCO
Martine Rothblatt, directora ejecutiva de United Therapeutics, vende acciones por 5,54 millones de dólares
Zymeworks presenta resultados del ensayo del fármaco ZW191 para cáncer de ovario
El CTO de Immunovant, Jay Stout, vende acciones por 75.099 dólares
Directora de HealthStream Linda Rebrovick vende 420.000 dólares en acciones
El CFO de Allogene Therapeutics, Geoffrey Parker, vende acciones por 48.698 dólares
Líderes de crecimiento Acciones del sector sanitario
NIVF NewGenIvf Group Limited - Class A Ordinary Shares | 1.46 | +873.33% |
BOLT Bolt Biotherapeutics, Inc. - Common Stock | 6.27 | +49.64% |
ESLA Estrella Immunopharma, Inc. - Common Stock | 0.99 | +35.62% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.2399 | +26.33% |
NAUT Nautilus Biotechnology, Inc. - Common Stock | 3.24 | +24.62% |
LUCD Lucid Diagnostics Inc. - Common Stock | 0.41 | +24.24% |
QSI Quantum-Si Incorporated - Class A Common Stock | 1.40 | +21.74% |
BEATW Heartbeam, Inc. - Warrant | 0.0129 | +21.70% |
Líderes de caída Acciones del sector sanitario
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0011 | -74.42% |
AARD Aardvark Therapeutics, Inc. - Common Stock | 1.39 | -64.81% |
BIAFW bioAffinity Technologies, Inc. - Warrant | 0.2204 | -47.41% |
LNAI Lunai Bioworks Inc. - Common Stock | 0.29 | -38.30% |
MGNX MacroGenics, Inc. - Common Stock | 2.25 | -38.02% |
NUWE Nuwellis, Inc. - Common Stock | 0.32 | -34.69% |
GCTK GlucoTrack, Inc. - Common Stock | 0.41 | -31.67% |
CATX Perspective Therapeutics, Inc. Common Stock | 1.60 | -28.89% |